Home » Topics » BioWorld Science

BioWorld Science
RSS

Venglustat shows favorable safety and tolerability and biologic activity in healthy volunteers

April 27, 2018

Amgen profiles pipeline progress of first quarter 2018

April 27, 2018

U.S. Department of Health & Human Services, Codagenix patent novel RSV vaccine

April 27, 2018

Oppilotech awarded grant for bacterial cell wall model

April 27, 2018

AbbVie, Galapagos discover new CFTR modulators

April 27, 2018

Novel STAT5 inhibitors synthesized at Freie Universitaet Berlin

April 27, 2018

Asavi presents inhibitors of HCV NS5B polymerase, HBV DNA polimerase and HIV-1 reverse transcriptase

April 27, 2018

Positive outcome of interim analysis of STRIDE-1 study of AXS-05

April 27, 2018

Achaogen receives funds to support development of aminoglycoside antibiotics

April 27, 2018

Orion Pharma enrolls participants in first-in-human study of ODM-208

April 27, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 22, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...